• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Ejim Mark: Digital Health Runs the Risk of Exacerbating Disparities

Video

Digital health can improve care around the world, but if used poorly could exacerbate existing disparities, said Ejim E. Mark, MD, MPH, MBA, CEO and founder of Access Healthcare Foundation.

This page contains sponsored advertising.

Digital health can improve care around the world, but if used poorly could exacerbate existing disparities, said Ejim E. Mark, MD, MPH, MBA, CEO and founder of Access Healthcare Foundation.

Transcript

How have you seen digital health improve care around the world?

A lot of people have a lot of access to health information and in developed countries you have more informed patients. The good thing is in developing countries, or resource-poor countries, you’re finding that even patients that don’t have access to doctors are able to search on the internet and get answers to basic questions around their health.

Is digital health helping to close disparity gaps, or can it exacerbate them?

It can exacerbate the gap if used poorly. But, it’s important for you to know your audience. Because when you look at individuals that have disposable income this digital health helps a lot. For example, the Amazon Echo can be a source for people who are actually finding basic questions around health. There’s a kids’ version right now where you can ask Amazon Echo or Alexa what the dose for your Tylenol, for example can be.

But, when you look at the other part of it, where you look at individuals that don’t have a lot of disposable income, there’s all this amazing digital data or technology out there that they don’t have access to. And people assume that they might have it because they have a cell phone or a mobile phone and that gap keeps increasing not just because of the digital divide but the resources as well.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.